WallStreetZenWallStreetZen

NASDAQ: EDSA
Edesa Biotech Inc Stock

$4.45-0.19 (-4.09%)
Updated Jun 11, 2024
EDSA Price
$4.45
Fair Value Price
$1.84
Market Cap
$14.31M
52 Week Low
$2.46
52 Week High
$8.33
P/E
-1.88x
P/B
3.31x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$7.25M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.5
Operating Cash Flow
-$6M
Beta
0.95
Next Earnings
Aug 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

EDSA Overview

Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EDSA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

EDSA ($4.45) is overvalued by 141.55% relative to our estimate of its Fair Value price of $1.84 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
EDSA ($4.45) is not significantly undervalued (141.55%) relative to our estimate of its Fair Value price of $1.84 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
EDSA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more EDSA due diligence checks available for Premium users.

Be the first to know about important EDSA news, forecast changes, insider trades & much more!

EDSA News

Valuation

EDSA fair value

Fair Value of EDSA stock based on Discounted Cash Flow (DCF)
Price
$4.45
Fair Value
$1.84
Overvalued by
141.55%
EDSA ($4.45) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
EDSA ($4.45) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
EDSA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

EDSA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.88x
Industry
-3.83x
Market
29.53x

EDSA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.31x
Industry
6.25x
EDSA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

EDSA's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.9M
Profit Margin
0%
EDSA's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$6.5M
Liabilities
$2.2M
Debt to equity
0.5
EDSA's short-term assets ($4.24M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EDSA's short-term assets ($4.24M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EDSA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
EDSA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.7M
Investing
$0.0
Financing
$211.7k
EDSA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

EDSA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
EDSA$14.31M-4.09%-1.88x3.31x
APTO$14.35M-3.30%-0.14x104.76x
MNPR$14.25M+5.16%-1.57x1.91x
CMMB$14.22M0.00%-0.64x1.07x
GLTO$14.42M-1.48%-0.47x0.51x

Edesa Biotech Stock FAQ

What is Edesa Biotech's quote symbol?

(NASDAQ: EDSA) Edesa Biotech trades on the NASDAQ under the ticker symbol EDSA. Edesa Biotech stock quotes can also be displayed as NASDAQ: EDSA.

If you're new to stock investing, here's how to buy Edesa Biotech stock.

What is the 52 week high and low for Edesa Biotech (NASDAQ: EDSA)?

(NASDAQ: EDSA) Edesa Biotech's 52-week high was $8.33, and its 52-week low was $2.46. It is currently -46.6% from its 52-week high and 80.89% from its 52-week low.

How much is Edesa Biotech stock worth today?

(NASDAQ: EDSA) Edesa Biotech currently has 3,215,968 outstanding shares. With Edesa Biotech stock trading at $4.45 per share, the total value of Edesa Biotech stock (market capitalization) is $14.31M.

Edesa Biotech stock was originally listed at a price of $2,766.54 in Nov 5, 2015. If you had invested in Edesa Biotech stock at $2,766.54, your return over the last 8 years would have been -99.84%, for an annualized return of -55.25% (not including any dividends or dividend reinvestments).

How much is Edesa Biotech's stock price per share?

(NASDAQ: EDSA) Edesa Biotech stock price per share is $4.45 today (as of Jun 11, 2024).

What is Edesa Biotech's Market Cap?

(NASDAQ: EDSA) Edesa Biotech's market cap is $14.31M, as of Jun 13, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Edesa Biotech's market cap is calculated by multiplying EDSA's current stock price of $4.45 by EDSA's total outstanding shares of 3,215,968.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.